Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in IPHA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Lion Point Capital, LP | 81K | $104K | 0.0% | 0.086% | 0.62% |
| 2 | MORGAN STANLEY | 44K | $56K | -6.2% | 0.046% | 0.00% |
| 3 | JANE STREET GROUP, LLC | 43K | $56K | -53.3% | 0.046% | 0.00% |
| 4 | MILLENNIUM MANAGEMENT LLC | 10K | $13K | -50.4% | 0.011% | 0.00% |
| 5 | RHUMBLINE ADVISERS | 5K | $6K | -9.0% | 0.005% | 0.00% |
| 6 | UBS Group AG | 861 | $1K | -9.1% | 0.001% | 0.00% |
| 7 | GAMMA Investing LLC | 240 | $307 | -77.6% | 0.000% | 0.00% |
| 8 | Farther Finance Advisors, LLC | 10 | $14 | 0.0% | 0.000% | 0.00% |
| 9 | Caitong International Asset Management Co., Ltd | 2 | $3 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in IPHA — a direct measure of their conviction.
Filings activity in IPHA during Q1 2026, grouped by how each filer changed its position.
No institutions added to their position this quarter.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 9 | 18% | 0.14% | 0.15 pp | $0M | 51% |
| Q4 2025 | 11 | +22% | 0.29% | +0.19 pp | $0M | +206% |
| Q3 2025 | 9 | 10% | 0.10% | 0.01 pp | $0M | 11% |
| Q2 2025 | 10 | 9.1% | 0.11% | 0.06 pp | $0M | 36% |
| Q1 2025 | 11 | +10% | 0.17% | +0.02 pp | $0M | +9.9% |
| Q4 2024 | 10 | +11% | 0.15% | 0.18 pp | $0M | 53% |
| Q3 2024 | 9 | +0.0% | 0.33% | +0.05 pp | $1M | +16% |
| Q2 2024 | 9 | — | 0.28% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying IPHA stock.
Based on Q1 2026 13F filings, institutional ownership of Innate Pharma S.A. stands at 0.1%, held across 9 reporting institutions.
Lion Point Capital, LP is the largest reported institutional holder of IPHA, with approximately 81,151 shares worth $0.00B as of Q1 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of IPHA, including JANE STREET GROUP, LLC, MILLENNIUM MANAGEMENT LLC.
Our composite Smart Money Score for IPHA is 44 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
1 institutions opened new positions in IPHA during Q1 2026, while 3 fully exited. 0 added to existing positions and 8 trimmed.
IPHA institutional ownership fell by 0.15 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 100.0% of all reported 13F value in IPHA, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Innate Pharma S.A. (IPHA) Institutional Ownership